Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial
- Resource Type
- Article
- Source
- The Lancet; November-December 2022, Vol. 400 Issue: 10366 p1858-1868, 11p
- Subject
- Language
- ISSN
- 01406736; 1474547X